Navigation Links
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Date:7/29/2010

ANA598 demonstrated potent antiviral activity, including median end-of-treatment declines in viral load ranging from 2.4 to 2.9 log10 in a three day monotherapy study in treatment-naïve genotype 1 patients.  ANA598 has also demonstrated a very favorable resistance profile.

Anadys has completed two long-term chronic toxicology studies of ANA598 (26 weeks duration in rats and 39 weeks duration in monkeys).  The No Observed Adverse Effect Level, or NOAEL, is 1000 mg/kg, the highest dose tested, in both the rat and monkey.  The completed toxicology studies support the ongoing Phase II clinical study as well as future clinical studies of longer duration.

Anadys has presented in vitro data supporting the use of ANA598 in combination with interferon-alpha as well as with other anti-HCV agents currently in development that act through diverse mechanisms.  In particular, data has shown that ANA598 is synergistic in vitro with interferon-alpha as well as representative HCV protease inhibitors, polymerase inhibitors, NS5A inhibitors and cyclophilin inhibitors.  In vitro combination treatment at clinically relevant concentrations of ANA598 with interferon-alpha as well as DAAs from multiple classes results in clearance of HCV RNA from cells rather than selection of resistant isolates.  Furthermore, ANA598 retains full activity in vitro against mutations conferring resistance to protease inhibitors, nucleoside polymerase inhibitors and non-nucleoside polymerase inhibitors that act at binding sites distinct from that of ANA598, while protease and nucleoside polymerase inhibitors retain full activity in vitro against mutations conferring resistance to ANA598.

ANA598 has received Fast Track Status from the FDA for the treatment of chronic hepatitis C.

Safe Harbor Statement


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... , President and Chief Executive Officer, will present ... Global Investment Conference, sponsored by H.C. Wainwright ... September 8-10, 2015 at the St. Regis Hotel ...
(Date:9/2/2015)... LAVAL, Quebec , Sept. 2, 2015  Valeant ... VRX) today announced that its affiliate has entered into ... USA , Inc. (NASDAQ: SURG ... to the upfront cash payment, Synergetics stockholders will receive ... if specified sales milestones are achieved following the closing.  ...
(Date:9/2/2015)... 2, 2015 Tumultuous market conditions – including ... care M&A activity – have led more than half ... pharmaceutical sales reps. This marks the first time that ... the halfway point, according to the spring 2015 ... ZS . AccessMonitor™ aggregates ...
Breaking Medicine Technology:RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5
(Date:9/2/2015)... ... 02, 2015 , ... Michael Elliot Media announces a crowdfunding campaign on indiegogo.com ... primary love interest in the film. The campaign is being called Project Plus-Size ... what we think,” Michael Elliot, an award-winning screenwriter and CEO of Michael Elliot Media, ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... combining both naturopathic and allopathic medicine, opens its second location this week at ... features roughly 1000 square feet of lounge space for patients to relax while ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... and fastest-growing interim clinical staffing companies, has completed a recapitalization with new ... , BPOC and Heritage Group each offer extensive expertise and connections ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China ... international investment and business conference will be hosted at five star Beijing Kunlun ... full-weekend networking conference will feature leading EB-5 industry professionals and Chinese private equity ...
(Date:9/2/2015)... ... September 02, 2015 , ... World Patent ... Pocket Cop, a safety invention that protects people from crime and other hostile ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "The industry ...
Breaking Medicine News(10 mins):Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... JACKSONVILLE, Fla., Aug. 25 In their effort ... successful and well-adjusted,Wounded Warrior Project (WWP) partnered with ... leaders & the Insurance Industry,Charitable Foundation (IICF) on ... pilot program. The program gave 11 wounded,warriors, most ...
... children hurt their classmates, math and reading scores ... by economists at the University of California, Davis, ... in the Classroom: How Children Exposed to Domestic ... by the National Bureau of Economic Research and ...
... Names invivodata to 2008 Pittsburgh 100, PITTSBURGH, ... electronic patient reported outcomes (ePRO) solutions and,services for ... Times has recognized the company in the "2008 ... in Western,Pennsylvania., "We see the Pittsburgh 100 ...
... faster this fall for every medical student in the country. ... resident must pass will be delivered in a new way: ... that some say has become an Achilles heel in the ... residents out there taking this test know they don,t have ...
... Exhibits at this week,s National Association of Chain Drug Store ... for enhanced patient safety and the benefits of pharmacy technician ... ... (PRWEB) August 25, 2008 - The https://www.ptcb.org/ [Pharmacy ...
... ranks No. 96 on the, 2008 Inc. 500, with three-year ... ... Aug. 25 Inc. magazine today ranked The,Coding Source No. 96 on ... U.S. The list is the most,comprehensive look at the most important segment ...
Cached Medicine News:Health News:Wounded Warrior Project (WWP), St. John's University, and Insurance Industry Charitable Foundation Partner to Assist Wounded Warriors 2Health News:Troubled children hurt peers' test scores, behavior 2Health News:Troubled children hurt peers' test scores, behavior 3Health News:invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies 2Health News:Listen up! 2Health News:Pharmacy Technician Certification Board (PTCB) Exhibits at 2008 NACDS Pharmacy & Technology Conference 2Health News:Pharmacy Technician Certification Board (PTCB) Exhibits at 2008 NACDS Pharmacy & Technology Conference 3Health News:The Coding Source Named to Inc. Magazine's 27th Annual List of America's 500 Fastest-Growing Private Companies 2Health News:The Coding Source Named to Inc. Magazine's 27th Annual List of America's 500 Fastest-Growing Private Companies 3
... Knee w/MultiLock Polyamide Hinge Wraparound ... an individualized fit. Multilock polyamide ... Flexion and extension can be ... and support level. Provides medial/lateral ...
... The Knee Cryo/Cuff combines the therapeutic benefits of ... cold to minimize pain. The cuff is anatomically ... cryotherapy. The Knee Cryo/Cuff is available in three ... a pediatric size, designed for children 1 - ...
Designed to provide continuous cold therapy to the shoulder and back. Helps to reduce pain and swelling and speed rehab....
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
Medicine Products: